Becky Cap, a 20-year veteran of the life sciences industry, was named chief operating officer of San Antonio-based GenCure in February, 2016. GenCure, a subsidiary of BioBridge Global, is focused on manufacturing advanced therapies for the cell and cell-gene market. GenCure’s mission is to realize the potential of donated human cells and tissue to save and enhance lives.
Cap, a native of Texas, began her career at Dana-Farber Cancer Institute in Boston, where she gained clinical, laboratory and regulatory experience, steeped in a no-holds-barred culture focused on finding innovative solutions to cancer treatment. She transitioned to industry and began a decade plus career consulting with large pharma and biotech firms on biomedical product development and commercialization for US and global development. Her work at Eidetics, a strategic research and consulting firm, focused on new biologic pathways for treating complex conditions starting with chemotherapeutics, leading monoclonal antibodies, tyrosine kinase inhibitors and bio-oncology agents, including PD-1 and PDL-1 inhibitors. Her expertise was honed as Oncology became an active and competitive “market” in which physicians and patients had multiple treatment options available to them for their cancers. Hers was one of the first Oncology Consulting Practices in this strategic marketing and market research space. She also has run her own consulting firm and worked with a number of local startups in the San Antonio community.
Cap is an active member of local and national committees on Regenerative Medicine and Cell Therapy, two private company Boards of Directors and the Governing Committee for Seton Home. Additionally, Cap is a co-founder and founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs. She holds a bachelor’s degree from Harvard University and an MBA from the Questrom School of Management at Boston University.